Clinical Studies | St. Agnes Hospital

Clinical Research Center

Current Studies

General Research

New subcutaneous entity for PE/DVT
Novel therapy for neuropathic pain
Tumor collection (ASTERAND)
Pancreatic tumor collection
Protease inhibitor regimen optimization in HIV
Evaluation of cardiac risk in arthritis patients – a COX-2 inhibitor vs. NSAIDs
Novel oral anticoagulant for DVT treatment and prevention
Combination opiate agonist and serotonin-norepinephrine reuptake inhibitor for post-op pain
A new entity for the treatment of endometriosis

Oncology Research Patient Populations

Metastatic Melanoma
Anemia in patients with non-myeloid malignancies
Palliative care for patients with bone metastases form lung, breast, or prostate
Newly diagnosed glioblastoma
Women with node-negative breast cancer
Assessment of clinical cancer tests
Palpable and operative breast cancer
Breast cancer – Stage 0, 1, or 2
Metastatic breast cancer – men and women
Hormone receptor positive post-menopausal women who have competed 5 years of hormone therapy
Bone metastases with breast cancer
Metastatic colorectal cancer
Stage II colon cancer with high recurrence risk
Head and neck cancer, stage III and IV previously untreated
Locally advanced head and neck cancers
Gleevec resistant or intolerant CML in blast crisis, accelerated phase, or chronic phase
Locally advanced non-small cell lung cancer
Advanced or metastatic NSCLC
I-ELCAP registry for lung cancer screening
Progressive peripheral T-cell lymphoma
Low tumor burden indolent non-Hodgkins lymphoma
Newly diagnosed multiple myeloma
Androgen-independent metastatic prostate adenocarcinoma
Hormone-refractory prostate cancer +/-metastases
Patients at risk for developing prostate cancer
Patients treated with radiation and long-term LHRH agonists for prostate cancer, prevention of osteoporosis and associated fractures
Resected renal cell carcinoma
Nausea and vomiting secondary to moderately emetogenic chemotherapy
Metastatic colorectal cancer evaluating second-line therapy
Leukemia – newly diagnosed previously untreated CML in chronic phase

Cardiology Research

Biomarkers to evaluate outcomes in patients with no ST segment elevation (pro-BNP)
ACS biomarkers study (MIDAS)

For more information, please call 410-368-8620 or e-mail us at research@stagnes.org. We would enjoy the opportunity to help you with your research challenges.